PUBLISHER: The Business Research Company | PRODUCT CODE: 1500014
PUBLISHER: The Business Research Company | PRODUCT CODE: 1500014
Cannabigerol (CBG) gummies are edible products infused with cannabigerol, a cannabinoid found in cannabis plants. These gummies typically contain a specific dosage of CBG extract along with other ingredients, offering a tasty and convenient way to consume CBG. They are popular among individuals seeking potential health benefits associated with CBG, such as its anti-inflammatory, neuroprotective, and mood-regulating properties.
The primary categories of CBG gummies include cannabidiol (CBD) edibles and combinations of cannabigerol (CBG) and cannabinol (CBN). Cannabidiol edibles are food products infused with cannabidiol, a compound derived from cannabis known for its potential therapeutic effects. CBG gummies are available in various flavors such as raspberry juice, strawberry juice, cherry juice, strawberry puree, raspberry powder, and others, offered in both hard candy and soft candy forms.
The cannabigerol (CBG) gummies research report is one of a series of new reports from The Business Research Company that provides cannabigerol (CBG) gummies market statistics, including the cannabigerol (CBG) gummies industry's global market size, regional shares, competitors with a cannabigerol (CBG) gummies market share, detailed cannabigerol (CBG) gummies market segments, market trends and opportunities, and any further data you may need to thrive in the cannabigerol (CBG) gummies industry. This cannabigerol (CBG) gummies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cannabigerol (CBG) gummies market size has grown exponentially in recent years. It will grow from $1.40 billion in 2023 to $2.03 billion in 2024 at a compound annual growth rate (CAGR) of 45.4%. The historical growth can be attributed to several factors, including the legalization of cannabis, increasing consumer awareness, ongoing product innovation, and the development of effective distribution channels.
The cannabigerol (CBG) gummies market size is expected to see exponential growth in the next few years. It will grow to $9.11 billion in 2028 at a compound annual growth rate (CAGR) of 45.6%. The anticipated growth in the forecast period can be linked to various factors, such as the regulatory landscape, prevailing health and wellness trends, competitive market dynamics, and investments in research and development. Key trends expected during this period encompass customization and personalization of products, premiumization strategies, emphasis on transparency and traceability, and the diversification of distribution channels.
The growing prevalence of anxiety is expected to drive the expansion of the cannabigerol (CBG) gummies market. Anxiety, a psychological condition marked by excessive worry and nervousness alongside physical symptoms such as palpitations, is on the rise due to various factors such as stress, trauma, genetic predispositions, and environmental influences. Cannabigerol (CBG) gummies are increasingly sought after for anxiety relief because of CBG's potential to interact with the endocannabinoid system, impacting neurotransmitter activity and potentially promoting relaxation and stress alleviation. For instance, data from the Australian Institute of Health and Welfare in February 2024 revealed that an estimated 23% of Australian males and 34% of females aged 16 to 85 have experienced some form of anxiety disorder in their lives. Consequently, the growing prevalence of anxiety is expected to boost the demand for cannabigerol (CBG) gummies.
Major companies in the cannabigerol (CBG) gummies market are innovating by developing products with natural ingredients to cater to the increasing demand for wellness-focused cannabinoid products. Gummies made with natural ingredients incorporate organic and plant-based components, ensuring a wholesome and pure consumption experience. For example, Rare Cannabinoid Company launched THC + CBG Relief Gummies in November 2023, a blend of Delta-9-THC, CBG, and CBD designed to naturally support physical well-being. These gummies, infused with green apple flavor, offer 2.5mg of Delta-9-THC, 30mg of CBG, and 10mg of CBD per gummy, providing a convenient and enjoyable way to explore the potential benefits of these cannabinoids.
In October 2021, Cronos Group partnered with Ginkgo Bioworks to create innovative CBG products such as the SPINACH FEELZ Chill Bliss 2,1 THC|CBG gummy. This collaboration aims to utilize fermentation techniques and unique methodologies to produce CBG without relying on the cannabis plant. Ginkgo Bioworks, a US-based biotech company, brings expertise in biotechnology to the partnership, facilitating the development of groundbreaking CBG products such as the SPINACH FEELZ gummy.
Major companies operating in the cannabigerol (CBG) gummies market are Curaleaf Holding Inc., The Cronos Group, Charlotte's Web Holdings Inc., Hemptown USA Inc., Green Roads LLC, Lazarus Naturals Inc., Medterra CBD LLC, ENDOCA, Extract Labs, NuLeaf Naturals LLC, Isodiol International Inc., CBDistillery, Elixinol Wellness Ltd., Joy Organics, CBD American Shaman, Steves Goods, Incredibles Edibles, Vida Optima LLC, CannaCare Health GmbH, FAB Nutrition LLC (dba FAB CBD), Demetrix Inc., Rare Cannabinod Company, Sunday Scaries, CanniLabs
North America was the largest region in the cannabigerol (CBG) gummies market in 2023. The regions covered in the cannabigerol (CBG) gummies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cannabigerol (CBG) gummies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cannabigerol (CBG) gummies market consists of sales of pure CBG gummies, broad spectrum CBG gummies, full spectrum CBG gummies, isolate CBG gummies, and CBG-infused gummies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cannabigerol (CBG) Gummies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cannabigerol (CBG) gummies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cannabigerol (CBG) gummies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cannabigerol (CBG) gummies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.